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THANK YOU!
• Lisa Schwartz PhD, Ani Chénier, MA, John Pringle, PhD, Matthew Hunt PhD, 
Oumou Bah-Sow, MD, PhD, Sékou Kouyaté, MA, Sonya De Laat, PhD, 
Gautham Krishnaraj MSc, Carrie Bernard, MD,  Lynda Redwood-Campbell, 
MD, FCFP, DTM&H, MPH, Laurie Elit, MD, MSc FRCS
• Colleagues (many in room)
• Study participants 
• $ Funders $  : R2HC & CIHR 
The weight of consent (structure of talk)
1. Overview of project and ‘data’ that is pt of departure for this talk
2. Slowing down, really listening to and thinking with West African 
study participants’ social rationales for participation in research
3. Consent and (mis)recognition
Part I:









The West Africa Ebola 
Virus Disease 
epidemic
Perceptions and moral experiences of EVD research
Humanitarian Healthcare Ethics, Guinean National Health Research Ethics Board, R2HC
Density of physicians per 1000 
Density of physicians per  1000

Perceptions and Moral Experiences of Ebola Research
Study objectives:
1) To deepen understanding of challenges and strategies for the                
ethical conduct of research during public health emergencies, 
with particular attention to the rolling out of clinical trials
2) To learn how Ebola quarantine and isolation disease control 
measures, such as voluntary consent, interacted with ethical 
standards of research interventions in Sierra Leone, Guinea, 
Liberia
3) To add evidence to existing recommendations for the ethical 
conduct of research in public health emergencies






-65 men, 43 women
-91% West African




















• “What motivated you to support, participate in, or 
decline participation in this research?
• “Did anything make you uncomfortable or leave 
you feeling troubled?”
• “What was done well?” 

(Antierens & Frontières,2014) 
“Doctor, do whatever you want to do, 
as long as I get better.” 
(P72)
“…those taking consent should exercise more time. Which 
unfortunately was not the case in the Ebola business…in that kind 
of situation, you just want to talk less and start the treatment.”
(P80)
Therapeutic optimism framing recruitment as the 
only ethical objective
• “You need to cajole them” 
Tx Misconception 
- vaccine
“They told us that if 
we got vaccinated, 
even if Ebola is in this 
area, we will be 
sheltered. That we will 








“During the outbreak, a lot of people came to help. It’s 
like somebody drowning and you are given a knife to hold. 
What do you do? You just have to hold a knife.” (P62)
INADEQUATE COMMUNICATIONS
• Trials started before final ethics approval
• Lack of clear info
• Survivors wanted to be and not consulted before studies 
approved
• Lack of post-trial communication = feeling used
Tx misconception
• Ethical / practical problem b/c
• Decision-making based in delusion/mis-information
• Can result in disappointment and loss of trust
“Consent or collaboration misconception” 
Harm –
disappointment, loss of trust feeling objectified and misled –
























Social connection rationales  animating participation 
in research
In ETU: “Emmanuel”
-Nurse recognizes family name: her family is from the same 
village 
“On the outside, I know you people have heard a lot of 
rumours, that the drugs that they offer you are going to kill 
you. You’re going to die. So I beg you, this is the drug that 
we give. It is an experimental drug that we are giving. But 
we know it is saving people. It is helping people to regain 
their strength, to regain their life. … So take it in.
•Nurse: “I am not here to harm you, I’m not 
here to kill you. I am your relative. I am your 
sister. So take it in. So I said OK, and I took it 
in.”
“…since I am an Ebola survivor, I know what 
was going on in the ETC, I could not just stay 
there like that, standing idly by with my arms 
crossed, refusing to give life to other people 
who were still suffering.” 
(P11)
...I had to contribute, in my way, to 
researching the disease.
(P34)
I know what I’ve undergone, I don’t want 
this disease affect any other citizens. 
(P55)
Why is this 
interesting? 
"It's got to be 
altruism," he 




(Mis)interpreting Consent & (Non)recognition
Nancy Fraser 2001, p. 6 
“Recognition or redistribution?” 
• Recognition is fundamental to any redistribution
• (Mis)recognition of those with less resources as not our peers at core 
of why and how inequities persist




“Systematic mis-recognition has led to forgetting or to the 
imposition of narratives that do not correspond to actual lived 
experiences. This in turn has had an impact upon how 




"he stared at her, but there was no 
sign of recognition on his face"
1. identification of someone or something or person from 
previous encounters or knowledge.
Thank you!
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